INNOVIVA, INC. Weighted Average Number of Shares, Restricted Stock
INNOVIVA, INC. (INVA) reported Weighted Average Number of Shares, Restricted Stock of 2.19 million shares for the 3-month period ending 2014-06-30, per its 10-Q filed 2014-08-07.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesRestrictedStock · last filed 2014-08-07
- INNOVIVA, INC. weighted average number of shares, restricted stock for the quarter ending 2014-06-30 was 2.19M shares, a 19.31% decline year-over-year.
- INNOVIVA, INC. weighted average number of shares, restricted stock for the quarter ending 2014-03-31 was 2.19M shares, a 21.73% decline year-over-year.
- INNOVIVA, INC. weighted average number of shares, restricted stock for the quarter ending 2013-09-30 was 2.42M shares, a 5.66% decline year-over-year.
- INNOVIVA, INC. weighted average number of shares, restricted stock for the quarter ending 2013-06-30 was 2.71M shares, a 2.77% increase year-over-year.
- INNOVIVA, INC. weighted average number of shares, restricted stock for fiscal 2013 was 2.36M shares, a 5.48% decline from fiscal 2012.
- INNOVIVA, INC. weighted average number of shares, restricted stock for fiscal 2012 was 2.50M shares, a 2.42% increase from fiscal 2011.
- INNOVIVA, INC. weighted average number of shares, restricted stock for fiscal 2011 was 2.44M shares, a 7300.00% increase from fiscal 2010.
- INNOVIVA, INC. weighted average number of shares, restricted stock for fiscal 2010 was 33.00K shares, a 42.11% decline from fiscal 2009.
| Period end | Weighted Average Number of Shares, Restricted Stock 3 month | Weighted Average Number of Shares, Restricted Stock 3 month as first filed | Weighted Average Number of Shares, Restricted Stock 6 month | Weighted Average Number of Shares, Restricted Stock 9 month | Weighted Average Number of Shares, Restricted Stock 12 month |
|---|---|---|---|---|---|
| 2014-06-30 | 2.19M shares 10-Q · filed 2014-08-07 | 2.19M shares 10-Q · filed 2014-08-07 | |||
| 2014-03-31 | 2.19M shares 10-Q · filed 2014-05-07 | ||||
| 2013-12-31 | 2.36M shares 10-K · filed 2014-03-03 | ||||
| 2013-09-30 | 2.42M shares 10-Q · filed 2013-11-01 | 2.42M shares 10-Q · filed 2013-11-01 | |||
| 2013-06-30 | 2.71M shares 10-Q · filed 2014-08-07 | 2.71M shares 10-Q · filed 2014-08-07 | |||
| 2013-03-31 | 2.80M shares 10-Q · filed 2014-05-07 | ||||
| 2012-12-31 | 2.50M shares 10-K · filed 2014-03-03 | ||||
| 2012-09-30 | 2.56M shares 10-Q · filed 2013-11-01 | 2.56M shares 10-Q · filed 2013-11-01 | |||
| 2012-06-30 | 2.64M shares 10-Q · filed 2013-08-01 | 2.64M shares 10-Q · filed 2013-08-01 | |||
| 2012-03-31 | 2.70M shares 10-Q · filed 2013-05-01 | -2.70M shares 10-Q · filed 2012-05-02 | |||
| 2011-12-31 | 2.44M shares 10-K · filed 2014-03-03 | ||||
| 2011-09-30 | 2.46M shares 10-Q · filed 2012-10-31 | 2.46M shares 10-Q · filed 2012-10-31 | |||
| 2011-06-30 | 2.45M shares 10-Q · filed 2012-08-01 | 2.45M shares 10-Q · filed 2012-08-01 | |||
| 2011-03-31 | -2.47M shares 10-Q · filed 2012-05-02 | ||||
| 2010-12-31 | 33.00K shares 10-K · filed 2013-02-26 | ||||
| 2009-12-31 | 57.00K shares 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |